Acutus Medical, Inc. (AFIB) Tops Q4 EPS by 5c; Offers Guidance

Acutus Medical, Inc. (NASDAQ: AFIB) reported Q4 EPS of ($0.63), $0.05 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $5 million versus the consensus estimate of $4.43 million.

GUIDANCE:

Acutus Medical, Inc. sees FY2023 revenue of $18-21 million, versus the consensus of $20.597 million.

For earnings history and earnings-related data on Acutus Medical, Inc. (AFIB) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Vera Bradley (VRA) Misses Q1 EPS by 26c ; Offers Guidance
• McGraw Hill (MH) Tops Q1 EPS by 15c, Beats on Revenue; Offers FY26 Revenue Guidance